Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation

Pediatric Transplantation

Volumn 10, Issue 4, 2006, Pages 479-486

  Kwon, Choon Hyuck David ^a   Suh, Kyung Suk ^a,b   Yi, Nam Joon ^a   Chang, Seong Hwan ^a   Cho, Yong Beom ^a   Cho, Jai Young ^a   Lee, Hoan Jong ^a   Seo, Jeong Kee ^a   Lee, Kuhn Uk ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

De novo hepatitis B; Hepatitis B core antibody; Hepatitis B surface antibody; Occult hepatitis; Prophylaxis

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPAVAX; PREDNISOLONE; RECOMBINANT HEPATITIS B VACCINE; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANTIBODY TITER; ARTICLE; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER FAILURE; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER PROTECTION; LIVER TRANSPLANTATION; MALE; ORGAN DONOR; PEDIATRIC SURGERY; RECIPIENT; SEROLOGY; TREATMENT RESPONSE;

CADAVER; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULINS; INFANT; LIVER TRANSPLANTATION; LIVING DONORS; MALE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; TIME FACTORS; TREATMENT OUTCOME; VACCINATION;

EID: 33646869649     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00540.x     Document Type: Article

References (24)

1. Roche B Samuel D Gigou M, et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 1997 : 26 : 517 526.
2. de Villa VH Chen YS Chen CL. Hepatitis B core antibody-positive grafts: recipient's risk. Transplantation 2003 : 75 : S49 S53.
3. Prieto M Gomez MD Berenguer M, et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl 2001 : 7 : 51 58.
4. Uemoto S Sugiyama K Marusawa H, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998 : 65 : 494 499.
5. Chen YS Wang CC de Villa VH, et al. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors. Clin Transplant 2002 : 16 : 405 409.
6. Dodson SF Bonham CA Geller DA Cacciarelli TV Rakela J Fung JJ. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 1999 : 68 : 1058 1061.
7. Ghany MG Ayola B Villamil FG, et al. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998 : 27 : 213 222.
8. Perrillo RP Wright T Rakela J, et al. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology 2001 : 33 : 424 432.
9. Chalasani N Smallwood G Halcomb J Fried MW Boyer TD. Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation Liver Transpl Surg 1998 : 4 : 128 132.
10. Van Thiel DH el-Ashmawy L Love K Gavaler JS Starzl TE. Response to hepatitis B vaccination by liver transplant candidates. Dig Dis Sci 1992 : 37 : 1245 1249.
11. Engler SH Sauer PW Golling M, et al. Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol 2001 : 13 : 363 367.
12. Arslan M Wiesner RH Sievers C Egan K Zein NN. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease. Liver Transpl 2001 : 7 : 314 320.
13. Loinaz C de Juanes JR Gonzalez EM, et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 1997 : 44 : 235 238.
14. Kallinowski B Benz C Buchholz L Stremmel W. Accelerated schedule of hepatitis B vaccination in liver transplant candidates. Transplant Proc 1998 : 30 : 797 799.
15. Sokal EM Ulla L Otte JB. Hepatitis B vaccine response before and after transplantation in 55 extrahepatic biliary atresia children. Dig Dis Sci 1992 : 37 : 1250 1252.
16. Chang SH Suh KS Yi NJ, et al. Active immunization against de novo hepatitis B virus infection in pediatric patients after liver transplantation. Hepatology 2003 : 37 : 1329 1334.
17. Alonso G Duca P Pasqualini T D'Agostino D. Evaluation of catch-up growth after liver transplantation in children with biliary atresia. Pediatr Transplant 2004 : 8 : 255 259.
18. Duca P Del Pont JM D'Agostino D. Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation. J Pediatr Gastroenterol Nutr 2001 : 32 : 168 170.
19. Sanchez-Fueyo A Martinez-Bauer E Rimola A. Hepatitis B vaccination after liver transplantation. Hepatology 2002 : 36 : 257 258 author reply 258 259.
20. Van Thiel DH. Vaccination of patients with liver disease: Who, when, and how. Liver Transpl Surg 1998 : 4 : 185 187.
21. Carey W Pimentel R Westveer MK Vogt D Broughan T. Failure of hepatitis B immunization in liver transplant recipients: Results of a prospective trial. Am J Gastroenterol 1990 : 85 : 1590 1592.
22. Lo CM Fung JT Lau GK, et al. Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B. Hepatology 2003 : 37 : 36 43.
23. Mendenhall C Roselle GA Lybecker LA, et al. Hepatitis B vaccination. Response of alcoholic with and without liver injury. Dig Dis Sci 1988 : 33 : 263 269.
24. Chisari FV Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995 : 13 : 29 60.